HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[New drugs approval: Lutetium-PSMA in metastatic castration-resistant prostate cancer].

AuthorsMatthieu Roulleaux Dugage, Friederike Schlürmann
JournalBulletin du cancer (Bull Cancer) Vol. 110 Issue 6 Pg. 600-602 (06 2023) ISSN: 1769-6917 [Electronic] France
Vernacular TitleNouvelles AMM : Lutetium-PSMA dans les cancers de prostates métastatiques résistants à la castration.
PMID37059642 (Publication Type: Letter)
Chemical References
  • Lutetium
  • Radiopharmaceuticals
  • Prostate-Specific Antigen
Topics
  • Male
  • Humans
  • Lutetium (therapeutic use)
  • Prostatic Neoplasms, Castration-Resistant (drug therapy, pathology)
  • Radiopharmaceuticals
  • Prostate-Specific Antigen
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: